Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Dr-Toh-Han-Chong"

1 News Found

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
Biotech | May 09, 2022

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer